Page last updated: 2024-10-30

letrozole and Vaginal Diseases

letrozole has been researched along with Vaginal Diseases in 4 studies

Vaginal Diseases: Pathological processes of the VAGINA.

Research Excerpts

ExcerptRelevanceReference
"Endocrine treatments of breast cancer patients antagonize estrogen and may lead to consequences of estrogen deprivation including menopausal symptoms."6.71Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. ( Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I, 2004)
"Endocrine treatments of breast cancer patients antagonize estrogen and may lead to consequences of estrogen deprivation including menopausal symptoms."2.71Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients. ( Ameye, L; Carbonez, A; Christiaens, MR; Morales, L; Neven, P; Paridaens, R; Timmerman, D; Van Huffel, S; Van Limbergen, E; Vergote, I, 2004)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kyvernitakis, I1
Ziller, V1
Hars, O1
Bauer, M1
Kalder, M1
Hadji, P1
Ferrero, S2
Leone Roberti Maggiore, U1
Scala, C1
Di Luca, M1
Venturini, PL1
Remorgida, V2
Morales, L1
Neven, P1
Timmerman, D1
Christiaens, MR1
Vergote, I1
Van Limbergen, E1
Carbonez, A1
Van Huffel, S1
Ameye, L1
Paridaens, R1
Abbamonte, HL1
Ragni, N1
Fulcheri, E1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Light Emitting Diode for the Treatment of Genitourinary Syndrome of Menopause Associated With Hormonal Therapy for Treating Breast Cancer: Randomized Controlled Clinical Trial[NCT03833726]77 participants (Actual)Interventional2019-01-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

4 trials available for letrozole and Vaginal Diseases

ArticleYear
Prevalence of menopausal symptoms and their influence on adherence in women with breast cancer.
    Climacteric : the journal of the International Menopause Society, 2014, Volume: 17, Issue:3

    Topics: Aged; Anastrozole; Antineoplastic Agents, Hormonal; Anxiety; Aromatase Inhibitors; Breast Neoplasms;

2014
Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies.
    Archives of gynecology and obstetrics, 2013, Volume: 287, Issue:3

    Topics: Adult; Aromatase Inhibitors; Calcium; Cholecalciferol; Contraceptives, Oral, Sequential; Contracepti

2013
Acute effects of tamoxifen and third-generation aromatase inhibitors on menopausal symptoms of breast cancer patients.
    Anti-cancer drugs, 2004, Volume: 15, Issue:8

    Topics: Anastrozole; Aromatase Inhibitors; Belgium; Body Mass Index; Breast Neoplasms; Data Interpretation,

2004
Letrozole and norethisterone acetate in rectovaginal endometriosis.
    Fertility and sterility, 2007, Volume: 88, Issue:3

    Topics: Administration, Oral; Aromatase Inhibitors; Contraceptives, Oral, Synthetic; Drug Therapy, Combinati

2007